[Pruritus and the hepatitis C virus. The MULTIVIRC Unit].
Hervé Dega(Institut Pasteur), O. Chosidow(Université Paris-Est Créteil), C. Françès(Navarre Institute of Health Research), P Opolon(Sorbonne Université), Christelle Blot, N. Dupin(Hôpital Cochin), Anne Simantov, C Callot, Thierry Poynard(Centre National de la Recherche Scientifique), Jean-Luc Laporte, C. Lebre
PubMed
January 1, 1998
Cited by 35
Related Papers
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
|Hepatology|1996|678
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235